ZM-182345
ZM-182345
ZM-182345 (pronunciation: Z-M-1-8-2-3-4-5) is a pharmacological agent that is often used in medical research to study the effects of P2Y1 receptor antagonism.
Etymology
The name "ZM-182345" is derived from the code assigned to it by its developers. The "ZM" stands for the initials of the pharmaceutical company that developed it, while "182345" is a unique identifier assigned to the compound during its development.
Pharmacology
ZM-182345 is a potent and selective antagonist of the P2Y1 receptor. This receptor is a type of G protein-coupled receptor that is activated by adenosine diphosphate (ADP), a molecule that plays a key role in cell signaling and platelet aggregation. By blocking the P2Y1 receptor, ZM-182345 can inhibit the effects of ADP, making it a useful tool for studying the role of this receptor in various physiological processes.
Related Terms
- Pharmacology: The branch of medicine that deals with the uses, effects, and modes of action of drugs.
- P2Y1 receptor: A type of G protein-coupled receptor that is activated by adenosine diphosphate (ADP).
- G protein-coupled receptor: A large family of cell surface receptors that respond to a variety of external signals.
- Adenosine diphosphate (ADP): A molecule that plays a key role in cell signaling and platelet aggregation.
- Cell signaling: The complex system of communication that governs basic cellular activities and coordinates cell actions.
- Platelet aggregation: The clumping together of platelets in the blood, a process that plays a key role in blood clotting.
External links
- Medical encyclopedia article on ZM-182345
- Wikipedia's article - ZM-182345
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski